The CoWrks Foundry partners with Yale University

World |  News | 0 Comment | 28 Feb, 2019

To address growing health and social disparities in India and around the globe, The CoWrks Foundry has partnered with Yale University with support from the RMZ Foundation, to launch the Sus...Read more

Bausch Health to acquire assets of Synergy Pharma

World |  News | 0 Comment | 27 Feb, 2019

Bausch Health Companies Inc. has announced that the Company was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals Inc. for a cash purchase price of appr...Read more

Gain Therapeutics SA announces funding support from a leading Parkinson's Research Foundation

World |  News | 0 Comment | 26 Feb, 2019

Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes involved in inborn errors of metabolism and in CNS diseases has annou...Read more

HOOKIPA Pharma raises $37.4M in Series D Financing

World |  News | 0 Comment | 26 Feb, 2019

HOOKIPA Pharma, a clinical stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platfor...Read more

Marinomed receives EUR 15M EIB financing

World |  News | 0 Comment | 26 Feb, 2019

The European Investment Bank (EIB) is providing EUR 15 million to Marinomed Biotech AG, a Vienna- based Biopharmaceutical Company developing innovative therapies for allergy, respiratory an...Read more

FDA & Flatiron Health expand Data Cancer Research collaboration

World |  News | 0 Comment | 27 Feb, 2019

Flatiron Health and the Information Exchange and Data Transformation (INFORMED) Program at the U.S. Food and Drug Administration (FDA) announced a two-year renewal and expansion of their re...Read more

Novartis to license Akcea-Ionis cardiac disease drug

World |  News | 0 Comment | 26 Feb, 2019

Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals announced that Novartis has exercised its option to license AKCEA-APO(a)-LRx, a drug to treat patients with elevated levels of...Read more

Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial

World |  News | 0 Comment | 25 Feb, 2019

Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs and a pioneer in gene regulatory and immunotherapeutic drugs utiliz...Read more

GE to sell Biopharma business for $21.4B to Danaher

World |  News | 0 Comment | 26 Feb, 2019

GE has announced a definitive agreement to sell its BioPharma business to Danaher Corporation for a total consideration of $21.4 billion, including $21 billion in cash as well as Danaher&rs...Read more

Sysmex Inostics’ OncoBEAM shows superior performance in mutation detection for HCC

World |  News | 0 Comment | 25 Feb, 2019

Data recently published in Clinical Cancer Research demonstrate the advantages of using an ultra-high sensitivity test for detection of mutations which may predict therapeutic eff...Read more

EC approves Pfizer's ZIRABEV, a biosimilar to Avastin

World |  News | 0 Comment | 25 Feb, 2019

Pfizer recently announced that the European Commission (EC) has approved ZIRABEV for the treatment of metastatic carcinoma of the colon or rectum, metastatic breast cancer, unresectabl...Read more

Roche to acquire Spark Therapeutics for $ 4.3B

World |  News | 0 Comment | 25 Feb, 2019

Roche and Spark Therapeutics have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics at a price of US$ 114.50 per share in an all-cash transaction. Thi...Read more

AbbVie and Voyager Therapeutics announce collaboration

World |  News | 0 Comment | 25 Feb, 2019

AbbVie, biopharmaceutical company and Voyager Therapeutics, a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases has announc...Read more

FDA grants priority review to Merck’s application for KEYTRUDA in SCLC

World |  News | 0 Comment | 22 Feb, 2019

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) for KEYTRUDA, Merck&rsq...Read more

Teva to apply Insilico’s predictive Digital Twins for biopharmaceutical production

World |  News | 0 Comment | 22 Feb, 2019

Insilico Biotechnology AG and Teva Pharmaceutical Industries Ltd. have announced an agreement to apply Insilico’s technology for predictive biomanufacturing to create and implement mo...Read more

WHO releases report on Global Health Expenditure

World |  News | 0 Comment | 22 Feb, 2019

Spending on health is growing faster than the rest of the global economy, accounting for 10% of global gross domestic product (GDP). A new report on global health expenditure from...Read more

Merck to acquire Immune Design in a $300M deal

World |  News | 0 Comment | 22 Feb, 2019

Merck , known as MSD outside the United States and Canada, and Immune Design, has announced that the companies have entered into a definitive agreement under which Merck, through a subsidia...Read more

Mallinckrodt presents analysis results for Therakos against aGvHD

World |  News | 0 Comment | 21 Feb, 2019

Mallinckrodt plc, a leading global specialty pharmaceutical company has announced interim analysis results of its company-sponsored, Phase 3, single-arm, open-label, multi-center study asse...Read more